Abstract Details
|
Robert C. Sergott, MD
(Wills Eye Hospital)
PRESENTER |
Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. |
| Rod Foroozan | No disclosure on file |
| R E. Faught, Jr., MD, FAAN (Emory University) | Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance. |
| W D. Shields, MD (UCLA) | No disclosure on file |
| Adam Ziemann, MD, PhD (Eli Lilly) | Dr. Ziemann has received personal compensation for serving as an employee of AbbVie. Dr. Ziemann has received stock or an ownership interest from AbbVie. |
| No disclosure on file | |
| Salma Sayeed, PharmD (Lundbeck) | No disclosure on file |
| No disclosure on file |